Ensure that over-the-counter naloxone is affordable.

Stakeholders emphasized the importance of affordability, urging the FDA and industry to ensure that the price point does not create a financial barrier for American families. On price point, stakeholders suggested a ceiling of $20 per unit, with suggested price between $5 and $20 per unit. On payment strategies, stakeholders shared recommendations for ensuring that payers continue to cover naloxone through prescription insurance plans, and offered options for how to use state and federal benefits to pay for needed overdose reversal medication.